Study type: randomized controlled trial
Absent of sugars and starches, keto diets tend to come with eating more protein anyway
In a Phase 2b obesity trial , AOD-9604 did not produce statistically significant weight loss versus placebo , and pharmaceutical development was discontinued around 2007 [3] [4]
Of course, your doctor can also provide you with personalized recommendations to help you achieve your weight-loss goals
In all three groups, subjects were in an upright position during the first 30 min after dosing, and no further liquid was allowed from 2 h before dosing until 30 min (reference) or 4 h (fed and fasting) after dosing, with no subsequent restrictions on liquid or food ingestion until the next pre-dose fasting period
Clinical data is overwhelmingly positive, and with growing interest among endocrinologists and obesity specialists in Pakistan, we expect: Official Drug Regulatory Authority of Pakistan (DRAP) approval soon Wider availability through hospitals and pharmacies Local clinical trials expanding into rural regions Greater awareness campaigns around metabolic health and obesity treatment With the right policies, pricing support, and education, Retatrutide could be a public health revolution for Pakistan